BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36978144)

  • 21. MR Diffusion Tractography to Identify and Characterize Microstructural White Matter Tract Changes in Systemic Lupus Erythematosus Patients.
    Shastri R; Shah G; Wang P; Cagnoli P; Schmidt-Wilcke T; McCune J; Harris R; Sundgren P
    Acad Radiol; 2016 Nov; 23(11):1431-1440. PubMed ID: 27746120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.
    Singh S; Gupta MK; Ahluwalia J; Singh P; Malhi P
    Rheumatol Int; 2009 Oct; 29(12):1455-61. PubMed ID: 19306097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Features and Outcomes of Neuropsychiatric Systemic Lupus Erythematosus in China.
    Zhang S; Li M; Zhang L; Wang Z; Wang Q; You H; Wang Y; Li M; Zeng X
    J Immunol Res; 2021; 2021():1349042. PubMed ID: 33532504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, outcome and prognostic factors of neuropsychiatric systemic lupus erythematosus: A real world single center study.
    Li X; Xiang X; Sun J; Liu S; Liu Y; Feng L; Li C; Li Z
    Mod Rheumatol; 2020 Mar; 30(2):321-326. PubMed ID: 30836042
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma and cerebrospinal fluid neurofilament light concentrations reflect neuronal damage in systemic lupus Erythematosus.
    Zervides KA; Janelidze S; Nystedt J; Gullstrand B; Nilsson P; Sundgren PC; Bengtsson AA; Hansson O; Jönsen A
    BMC Neurol; 2022 Dec; 22(1):467. PubMed ID: 36494778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of eye sign combined with increased interleukin-6 in cerebrospinal fluid in patients with neuropsychiatric lupus erythematosus.
    Shi LH; Liu ZY; Yu SJ; Xia Q; Zhao J; Wu R
    Int J Rheum Dis; 2023 Aug; 26(8):1464-1473. PubMed ID: 37366596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
    Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
    Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship Between Clinical and Immunological Features with Magnetic Resonance Imaging Abnormalities in Female Patients with Neuropsychiatric Systemic Lupus Erythematosus.
    Wang HP; Wang CY; Pan ZL; Zhao JY; Zhao B
    Chin Med J (Engl); 2016 Mar; 129(5):542-8. PubMed ID: 26904988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Systemic lupus erythematosus associated macrophage activation syndrome with neuropsychiatric symptoms: A report of 2 cases].
    Luo ZJ; Wu JJ; Song Y; Mei CL; DU R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1111-1117. PubMed ID: 38101797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated serum free IL-18 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders.
    Liang R; Zheng L; Ji T; Zheng J; Liu J; Yuan C; Huang Q; Yang M
    Lupus; 2022 Feb; 31(2):187-193. PubMed ID: 35042378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Novel Central Neuroinflammation Biomarkers.
    Labouret M; Costi S; Bondet V; Trebossen V; Le Roux E; Ntorkou A; Bartoli S; Auvin S; Bader-Meunier B; Baudouin V; Corseri O; Dingulu G; Ducrocq C; Dumaine C; Elmaleh M; Fabien N; Faye A; Hau I; Hentgen V; Kwon T; Meinzer U; Ouldali N; Parmentier C; Pouletty M; Renaldo F; Savioz I; Rozenberg F; Frémond ML; Lepelley A; Rice GI; Seabra L; Benoist JF; Duffy D; Crow YJ; Ellul P; Melki I
    J Clin Immunol; 2023 Apr; 43(3):615-624. PubMed ID: 36469191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement.
    Cohen D; Rijnink EC; Nabuurs RJ; Steup-Beekman GM; Versluis MJ; Emmer BJ; Zandbergen M; van Buchem MA; Allaart CF; Wolterbeek R; Bruijn JA; van Duinen SG; Huizinga TW; Bajema IM
    Rheumatology (Oxford); 2017 Jan; 56(1):77-86. PubMed ID: 28028157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
    Yoshio T; Okamoto H; Kurasawa K; Dei Y; Hirohata S; Minota S
    Lupus; 2016 Aug; 25(9):997-1003. PubMed ID: 26846690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study.
    Yu HH; Lee JH; Wang LC; Yang YH; Chiang BL
    Lupus; 2006; 15(10):651-7. PubMed ID: 17120591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil.
    Tanaka S; Kawaguchi T; Kudo R; Kimura M; Rikitake Y; Iwao C; Rikitake M; Iwao K; Aizawa A; Kariya Y; Matsuda M; Miyauchi S; Takajo I; Umekita K
    Intern Med; 2022 Oct; 61(20):3131-3135. PubMed ID: 35283391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different patterns of cerebral perfusion in SLE patients with and without neuropsychiatric manifestations.
    Zhuo Z; Su L; Duan Y; Huang J; Qiu X; Haller S; Li H; Zeng X; Liu Y
    Hum Brain Mapp; 2020 Feb; 41(3):755-766. PubMed ID: 31650651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
    Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW
    Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE).
    Zirkzee EJ; Huizinga TW; Bollen EL; van Buchem MA; Middelkoop HA; van der Wee NJ; le Cessie S; Steup-Beekman GM
    Lupus; 2014; 23(1):31-8. PubMed ID: 24243776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychiatric manifestations are associated with increased mortality in Indian patients with lupus: A single centre retrospective observational study.
    Pinto B; Suresh SC; Ramyasri K; Narayan G; Susan D; Manuel S; Wodeyar A; Shivanna A; Janardana R; Chanakya K; Charles BS; Nanjundaswamy SK; Desai AM; Nadig R; Shobha V
    Lupus; 2022 Nov; 31(13):1563-1571. PubMed ID: 36134692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different phenotypes of neuropsychiatric systemic lupus erythematosus are related to a distinct pattern of structural changes on brain MRI.
    Inglese F; Kant IMJ; Monahan RC; Steup-Beekman GM; Huizinga TWJ; van Buchem MA; Magro-Checa C; Ronen I; de Bresser J
    Eur Radiol; 2021 Nov; 31(11):8208-8217. PubMed ID: 33929569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.